Man Caught Using E-Cigarette with Illegal Substance on Train

Regulations by 2FIRSTS.ai
Jan.04.2024
Man Caught Using E-Cigarette with Illegal Substance on Train
A man was caught using an e-cigarette containing illegal substance on a train in Guangzhou, China.

According to a report by China News Network on January 3, the Guangzhou railway police recently successfully apprehended a man who was using an e-cigarette containing ethyl methylphenidate in the train restroom. The individual has been subjected to administrative penalties as per the law.

 

According to reports, this incident occurred on the Z111 train running between Ganzhou and Shaoguan East. A man was found lying in the restroom by the train police, using an e-cigarette alone. He appeared to be in a dazed state and showed no reaction to the sudden arrival of the police. After being woken up and questioned by the authorities, the man admitted to the fact that the e-cigarette contained the illegal substance ethyl methylamino cyclohexane. The train police then took the man to the police station at Guangzhou Station for further processing.

 

After undergoing urine drug testing, a man named Ma (pseudonym), 21 years old, unemployed, and holder of a standing ticket from Ganzhou to Shaoguan East, was confirmed to have tested positive for methamphetamine in his urine. Furthermore, he fully admitted to his illegal actions. According to Ma's recollection, he engaged in the use of an e-cigarette containing methamphetamine in the bathroom only after his phone became unusable. He also stated that he was well aware that methamphetamine had been officially classified as a narcotic and psychoactive drug, but still succumbed to impulsiveness and tried it a couple of times, ultimately being apprehended by the police. Currently, the Guangzhou Railway Police have lawfully punished Ma and confiscated his e-cigarette device and related items.

 

Since October 1, 2023, the use of methoxyflurane has officially been included in the list of anesthetic and psychotropic drugs. Any illegal activities such as use, smuggling, trafficking, transportation, or manufacturing involving methoxyflurane will be treated as a drug-related crime and prosecuted according to the law.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

BREAKING: China Brings Nicotine Pouches Under Tobacco Monopoly Regulation, Signaling Major Shift for Oral Products
BREAKING: China Brings Nicotine Pouches Under Tobacco Monopoly Regulation, Signaling Major Shift for Oral Products
China has for the first time issued clear regulatory rules for nicotine pouches and other oral nicotine products, formally classifying them under the tobacco monopoly alongside cigarettes and tobacco, ending a long-standing legal grey zone and laying the regulatory groundwork for their potential domestic launch.
Jan.09 by Alan Zhao | 2Firsts Perspectives
British Columbia Sues Juul Over Youth Nicotine Addiction
British Columbia Sues Juul Over Youth Nicotine Addiction
British Columbia has filed a civil lawsuit against Juul Labs, alleging the company fuelled youth nicotine addiction through highly addictive products and deceptive marketing practices. The claim was submitted to the B.C. Supreme Court under the newly enacted Vaping Product Damages and Health Care Costs Recovery Act.
Dec.15 by 2FIRSTS.ai
Imperial Brands’ blu adds “Creamy Tobacco” flavour, rolling out across device kits and pod products
Imperial Brands’ blu adds “Creamy Tobacco” flavour, rolling out across device kits and pod products
Imperial Brands’ vaping brand blu has outlined its flavour roadmap for 2026 on its official website, adding a new “Creamy Tobacco” flavour that has been rolled out across the rechargeable blu bar kit and its compatible blu kit pods. The brand describes the flavour as offering a more velvety tobacco taste.
Dec.19
South Korea’s appeal court again sides with KT&G, Philip Morris Korea and BAT Korea in $36.24 million case
South Korea’s appeal court again sides with KT&G, Philip Morris Korea and BAT Korea in $36.24 million case
South Korea’s National Health Insurance Service (NHIS) has again lost on appeal in its damages lawsuit against KT&G, Philip Morris Korea and BAT Korea, seeking ₩53.3 billion (about $36.244 million).
Jan.15 by 2FIRSTS.ai
Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model
Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model
The U.S. Food and Drug Administration has confirmed that six on! PLUS nicotine pouch products have received Marketing Granted Orders (MGO) through the PMTA pathway. The authorizations were completed under the agency’s nicotine pouch review pilot program in “record time,” with the FDA citing lower levels of harmful constituents while stressing that the decision applies only to the specified products and does not mean they are safe or FDA approved.
Regulations
Dec.20
Belgium: BAT plans to cut 51 jobs at Groot-Bijgaarden site, Brussels Morning Newspaper reports
Belgium: BAT plans to cut 51 jobs at Groot-Bijgaarden site, Brussels Morning Newspaper reports
British American Tobacco (BAT) has announced plans to cut 51 jobs at its Groot-Bijgaarden facility in Belgium, disclosed during a special works council meeting.
Jan.15 by 2FIRSTS.ai